Modest growth forecast for global CD market

The global market for cardiovascular disease (CVD) - comprised of heart failure (HF), myocardial infarction and acute coronary syndrome (ACS) - is expected to expand at a moderate rate, from $13.7 billion in 2012 to $18.2 billion by 2019, at a compound annual growth rate (CAGR) of 4.1%, forecasts business intelligence provider GBI Research.

The company’s latest report states that out of the eight major markets (the USA, France, Germany, Italy, Spain, UK, Japan and Canada), the USA will boast the largest value, from $6.1 billion in 2012 to $8.49 billion by 2019, at a higher CAGR of 4.7%.

This growth is partially due to the increase of the treatment population, which is forecast to jump from 14 million in 2012 to 16 million by 2019, at a CAGR of 1.6%.